The global Cell and Gene Therapy Manufacturing Quality Control market size was valued at USD 411.6 million in 2022 and is forecast to a readjusted size of USD 1325.4 million by 2029 with a CAGR of 18.2% during review period.
Report includes an overview of the development of the Cell and Gene Therapy Manufacturing Quality Control industry chain, the market status of Pharmaceutical & Biotechnology Companies (Sterility Testing, Purity Testing), Contract Manufacturing Organizations (Sterility Testing, Purity Testing), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Cell and Gene Therapy Manufacturing Quality Control.
Regionally, the report analyzes the Cell and Gene Therapy Manufacturing Quality Control markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell and Gene Therapy Manufacturing Quality Control market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell and Gene Therapy Manufacturing Quality Control market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell and Gene Therapy Manufacturing Quality Control industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Sterility Testing, Purity Testing).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell and Gene Therapy Manufacturing Quality Control market.
Regional Analysis: The report involves examining the Cell and Gene Therapy Manufacturing Quality Control market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell and Gene Therapy Manufacturing Quality Control market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell and Gene Therapy Manufacturing Quality Control:
Company Analysis: Report covers individual Cell and Gene Therapy Manufacturing Quality Control players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Cell and Gene Therapy Manufacturing Quality Control This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical & Biotechnology Companies, Contract Manufacturing Organizations).
Technology Analysis: Report covers specific technologies relevant to Cell and Gene Therapy Manufacturing Quality Control. It assesses the current state, advancements, and potential future developments in Cell and Gene Therapy Manufacturing Quality Control areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell and Gene Therapy Manufacturing Quality Control market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Bio-Rad Laboratories,Inc.
QIAGEN
Charles River Laboratories International, Inc.
Lonza Group AG
Bio-Techne Corporation
Merck KGaA
F. Hoffmann-La Roche Ltd
Thermo Fisher Scientific, Inc.
Intertek Group Plc
Eurofins Scientific S.E.
Sterility Testing
Purity Testing
Potency Testing
Identity Testing
Others
Pharmaceutical & Biotechnology Companies
Contract Manufacturing Organizations
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Cell and Gene Therapy Manufacturing Quality Control product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Cell and Gene Therapy Manufacturing Quality Control, with revenue, gross margin and global market share of Cell and Gene Therapy Manufacturing Quality Control from 2018 to 2023.
Chapter 3, the Cell and Gene Therapy Manufacturing Quality Control competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Cell and Gene Therapy Manufacturing Quality Control market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Cell and Gene Therapy Manufacturing Quality Control.
Chapter 13, to describe Cell and Gene Therapy Manufacturing Quality Control research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Cell and Gene Therapy Manufacturing Quality Control
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Cell and Gene Therapy Manufacturing Quality Control by Type
1.3.1 Overview: Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type in 2022
1.3.3 Sterility Testing
1.3.4 Purity Testing
1.3.5 Potency Testing
1.3.6 Identity Testing
1.3.7 Others
1.4 Global Cell and Gene Therapy Manufacturing Quality Control Market by Application
1.4.1 Overview: Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Contract Manufacturing Organizations
1.5 Global Cell and Gene Therapy Manufacturing Quality Control Market Size & Forecast
1.6 Global Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast by Region
1.6.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region, (2018-2029)
1.6.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Size and Prospect (2018-2029)
1.6.4 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size and Prospect (2018-2029)
1.6.6 South America Cell and Gene Therapy Manufacturing Quality Control Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Bio-Rad Laboratories,Inc.
2.1.1 Bio-Rad Laboratories,Inc. Details
2.1.2 Bio-Rad Laboratories,Inc. Major Business
2.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.1.4 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Bio-Rad Laboratories,Inc. Recent Developments and Future Plans
2.2 QIAGEN
2.2.1 QIAGEN Details
2.2.2 QIAGEN Major Business
2.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.2.4 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 QIAGEN Recent Developments and Future Plans
2.3 Charles River Laboratories International, Inc.
2.3.1 Charles River Laboratories International, Inc. Details
2.3.2 Charles River Laboratories International, Inc. Major Business
2.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.3.4 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Charles River Laboratories International, Inc. Recent Developments and Future Plans
2.4 Lonza Group AG
2.4.1 Lonza Group AG Details
2.4.2 Lonza Group AG Major Business
2.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.4.4 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Lonza Group AG Recent Developments and Future Plans
2.5 Bio-Techne Corporation
2.5.1 Bio-Techne Corporation Details
2.5.2 Bio-Techne Corporation Major Business
2.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.5.4 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bio-Techne Corporation Recent Developments and Future Plans
2.6 Merck KGaA
2.6.1 Merck KGaA Details
2.6.2 Merck KGaA Major Business
2.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.6.4 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Merck KGaA Recent Developments and Future Plans
2.7 F. Hoffmann-La Roche Ltd
2.7.1 F. Hoffmann-La Roche Ltd Details
2.7.2 F. Hoffmann-La Roche Ltd Major Business
2.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.7.4 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
2.8 Thermo Fisher Scientific, Inc.
2.8.1 Thermo Fisher Scientific, Inc. Details
2.8.2 Thermo Fisher Scientific, Inc. Major Business
2.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.8.4 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
2.9 Intertek Group Plc
2.9.1 Intertek Group Plc Details
2.9.2 Intertek Group Plc Major Business
2.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.9.4 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Intertek Group Plc Recent Developments and Future Plans
2.10 Eurofins Scientific S.E.
2.10.1 Eurofins Scientific S.E. Details
2.10.2 Eurofins Scientific S.E. Major Business
2.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
2.10.4 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Eurofins Scientific S.E. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cell and Gene Therapy Manufacturing Quality Control Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Cell and Gene Therapy Manufacturing Quality Control by Company Revenue
3.2.2 Top 3 Cell and Gene Therapy Manufacturing Quality Control Players Market Share in 2022
3.2.3 Top 6 Cell and Gene Therapy Manufacturing Quality Control Players Market Share in 2022
3.3 Cell and Gene Therapy Manufacturing Quality Control Market: Overall Company Footprint Analysis
3.3.1 Cell and Gene Therapy Manufacturing Quality Control Market: Region Footprint
3.3.2 Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Type Footprint
3.3.3 Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value and Market Share by Type (2018-2023)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application (2018-2023)
5.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Forecast by Application (2024-2029)
6 North America
6.1 North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2029)
6.2 North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2029)
6.3 North America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
6.3.1 North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2029)
6.3.2 United States Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
6.3.3 Canada Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
6.3.4 Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2029)
7.2 Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2029)
7.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
7.3.1 Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2029)
7.3.2 Germany Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
7.3.3 France Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
7.3.5 Russia Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
7.3.6 Italy Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Market Size by Region
8.3.1 Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2029)
8.3.2 China Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
8.3.3 Japan Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
8.3.4 South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
8.3.5 India Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
8.3.7 Australia Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
9 South America
9.1 South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2029)
9.2 South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2029)
9.3 South America Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
9.3.1 South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2029)
9.3.2 Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
9.3.3 Argentina Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Country
10.3.1 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2029)
10.3.2 Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
10.3.4 UAE Cell and Gene Therapy Manufacturing Quality Control Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Cell and Gene Therapy Manufacturing Quality Control Market Drivers
11.2 Cell and Gene Therapy Manufacturing Quality Control Market Restraints
11.3 Cell and Gene Therapy Manufacturing Quality Control Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Cell and Gene Therapy Manufacturing Quality Control Industry Chain
12.2 Cell and Gene Therapy Manufacturing Quality Control Upstream Analysis
12.3 Cell and Gene Therapy Manufacturing Quality Control Midstream Analysis
12.4 Cell and Gene Therapy Manufacturing Quality Control Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Bio-Rad Laboratories,Inc. Company Information, Head Office, and Major Competitors
Table 6. Bio-Rad Laboratories,Inc. Major Business
Table 7. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 8. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Bio-Rad Laboratories,Inc. Recent Developments and Future Plans
Table 10. QIAGEN Company Information, Head Office, and Major Competitors
Table 11. QIAGEN Major Business
Table 12. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 13. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. QIAGEN Recent Developments and Future Plans
Table 15. Charles River Laboratories International, Inc. Company Information, Head Office, and Major Competitors
Table 16. Charles River Laboratories International, Inc. Major Business
Table 17. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 18. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Charles River Laboratories International, Inc. Recent Developments and Future Plans
Table 20. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 21. Lonza Group AG Major Business
Table 22. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 23. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Lonza Group AG Recent Developments and Future Plans
Table 25. Bio-Techne Corporation Company Information, Head Office, and Major Competitors
Table 26. Bio-Techne Corporation Major Business
Table 27. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 28. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Bio-Techne Corporation Recent Developments and Future Plans
Table 30. Merck KGaA Company Information, Head Office, and Major Competitors
Table 31. Merck KGaA Major Business
Table 32. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 33. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Merck KGaA Recent Developments and Future Plans
Table 35. F. Hoffmann-La Roche Ltd Company Information, Head Office, and Major Competitors
Table 36. F. Hoffmann-La Roche Ltd Major Business
Table 37. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 38. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. F. Hoffmann-La Roche Ltd Recent Developments and Future Plans
Table 40. Thermo Fisher Scientific, Inc. Company Information, Head Office, and Major Competitors
Table 41. Thermo Fisher Scientific, Inc. Major Business
Table 42. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 43. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Thermo Fisher Scientific, Inc. Recent Developments and Future Plans
Table 45. Intertek Group Plc Company Information, Head Office, and Major Competitors
Table 46. Intertek Group Plc Major Business
Table 47. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 48. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Intertek Group Plc Recent Developments and Future Plans
Table 50. Eurofins Scientific S.E. Company Information, Head Office, and Major Competitors
Table 51. Eurofins Scientific S.E. Major Business
Table 52. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product and Solutions
Table 53. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Eurofins Scientific S.E. Recent Developments and Future Plans
Table 55. Global Cell and Gene Therapy Manufacturing Quality Control Revenue (USD Million) by Players (2018-2023)
Table 56. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Players (2018-2023)
Table 57. Breakdown of Cell and Gene Therapy Manufacturing Quality Control by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Cell and Gene Therapy Manufacturing Quality Control, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Cell and Gene Therapy Manufacturing Quality Control Players
Table 60. Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Type Footprint
Table 61. Cell and Gene Therapy Manufacturing Quality Control Market: Company Product Application Footprint
Table 62. Cell and Gene Therapy Manufacturing Quality Control New Market Entrants and Barriers to Market Entry
Table 63. Cell and Gene Therapy Manufacturing Quality Control Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Share by Type (2018-2023)
Table 66. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Forecast by Type (2024-2029)
Table 67. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2023)
Table 68. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Forecast by Application (2024-2029)
Table 69. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Cell and Gene Therapy Manufacturing Quality Control Raw Material
Table 100. Key Suppliers of Cell and Gene Therapy Manufacturing Quality Control Raw Materials
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Picture
Figure 2. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type in 2022
Figure 4. Sterility Testing
Figure 5. Purity Testing
Figure 6. Potency Testing
Figure 7. Identity Testing
Figure 8. Others
Figure 9. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application in 2022
Figure 11. Pharmaceutical & Biotechnology Companies Picture
Figure 12. Contract Manufacturing Organizations Picture
Figure 13. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Cell and Gene Therapy Manufacturing Quality Control Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Region in 2022
Figure 18. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Share by Players in 2022
Figure 24. Cell and Gene Therapy Manufacturing Quality Control Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Cell and Gene Therapy Manufacturing Quality Control Market Share in 2022
Figure 26. Global Top 6 Players Cell and Gene Therapy Manufacturing Quality Control Market Share in 2022
Figure 27. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Share by Type (2018-2023)
Figure 28. Global Cell and Gene Therapy Manufacturing Quality Control Market Share Forecast by Type (2024-2029)
Figure 29. Global Cell and Gene Therapy Manufacturing Quality Control Consumption Value Share by Application (2018-2023)
Figure 30. Global Cell and Gene Therapy Manufacturing Quality Control Market Share Forecast by Application (2024-2029)
Figure 31. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 41. France Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Region (2018-2029)
Figure 48. China Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 51. India Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Cell and Gene Therapy Manufacturing Quality Control Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Cell and Gene Therapy Manufacturing Quality Control Consumption Value (2018-2029) & (USD Million)
Figure 65. Cell and Gene Therapy Manufacturing Quality Control Market Drivers
Figure 66. Cell and Gene Therapy Manufacturing Quality Control Market Restraints
Figure 67. Cell and Gene Therapy Manufacturing Quality Control Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Cell and Gene Therapy Manufacturing Quality Control in 2022
Figure 70. Manufacturing Process Analysis of Cell and Gene Therapy Manufacturing Quality Control
Figure 71. Cell and Gene Therapy Manufacturing Quality Control Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
